Home

Differential
Counter

Flow
Tutorial

 

  
 
Myeloproliferative
neoplasms		 Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)		 MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms		 Mature B cell
neoplasms		 Mature T and NK
neoplasms		 Hodgkin
lymphoma		 Immunodeficiency associated
lymphoproliferative disorders		 Histiocytic and dendritic
cell neoplasms
 

Lymphocyte-Depleted Classical Hodgkin Lymphoma
  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
Nodular sclerosis classical Hodgkin lymphoma
Mixed cellularity classical Hodgkin lymphoma
Lymphocyte-rich classical Hodgkin lymphoma
Lymphocyte-depleted classical Hodgkin lymphoma
Nodular lymphocyte predominant Hodgkin lymphoma
Article Antigens evaluated
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. CD15, CD20, CD30, CD79a, CD138, EBV-LMP
The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. BSAP(PAX-5), Oct-2, BOB-1, CD20, CD22, CD79a
T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction. CD15, CD30, Pax-5, TCR beta gene rearrangement
Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. CD4, CD8, CD56, CD57, Perforin, TIA-1
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. CD30, Granzyme B, TIA-1, EBER